Granahan Investment Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-96,605
Closed -$6.2M 169
2026
Q1
$6.2M Buy
96,605
+65,695
+213% +$5.99M 0.3% 86
2025
Q4
$4.02M Buy
30,910
+7,201
+30% +$988K 0.17% 124
2025
Q3
$2.55M Buy
23,709
+12,159
+105% +$1.32M 0.1% 123
2025
Q2
$1.07M Buy
+11,550
New +$907K 0.04% 143

Other funds holding WGS

Granahan Investment Management's WGS Position: Q2 2026 in Review

Granahan Investment Management sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 96,605 shares — an estimated $6.2M sold.

Granahan Investment Management first reported a position in WGS in Q2 2025 and held it in 4 quarters. The position peaked at $6.2M in Q1 2026. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Granahan Investment Management reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Granahan Investment Management sold 96,605 GeneDx Holdings shares in Q2 2026, an estimated $6.2M.
  • Granahan Investment Management first reported a position in GeneDx Holdings in Q2 2025 and held it in 4 quarters.
  • Granahan Investment Management's GeneDx Holdings position peaked at $6.2M in Q1 2026.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.